Literature DB >> 27141

Susceptibility of skin and throat strains of group A streptococci to rosamicin and erythromycin.

G Saroglou, A L Bisno.   

Abstract

The minimal inhibitory concentrations of rosamicin and erythromycin were compared for 210 strains of group A streptococcus isolated from a diverse spectrum of streptococcal diseases. Of these strains, 97.6% were inhibited by 0.1 to 0.2 mug of rosamicin per ml, whereas 90.9% were inhibited by 0.025 to 0.05 mug of erythromycin per ml. The minimal inhibitory concentration of rosamicin for 154 strains exceeded that of erythromycin by at least fourfold. Five group A strains of streptococcus that were highly resistant to erythromycin were even more resistant to rosamicin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 27141      PMCID: PMC352314          DOI: 10.1128/AAC.13.4.701

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  IN VITRO SUSCEPTIBILITY OF GROUP A BETA HEMOLYTIC STREPTOCOCCI TO 18 ANTIBIOTICS.

Authors:  T C EICKHOFF; M FINLAND; C WILCOX
Journal:  Am J Med Sci       Date:  1965-03       Impact factor: 2.378

2.  EPIDEMIOLOGIC CHARACTERIZATION OF GROUP A STREPTOCOCCI BY T-AGGLUTINATION AND M-PRECIPITATION TESTS IN THE PUBLIC HEALTH LABORATORY.

Authors:  M D MOODY; J PADULA; D LIZANA; C T HALL
Journal:  Health Lab Sci       Date:  1965-07

3.  Susceptibility of hemolytic streptococci, other than those of group D, to eleven antibiotics in vitro.

Authors:  W F JONES; H A FELDMAN; M FINLAND
Journal:  Am J Clin Pathol       Date:  1957-02       Impact factor: 2.493

4.  Rosamicin: in vitro activity against anaerobes and comparison with erythromycin.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

5.  Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic.

Authors:  J A Waitz; C G Drube; E L Moss; M J Weinstein
Journal:  J Antibiot (Tokyo)       Date:  1972-11       Impact factor: 2.649

6.  Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin.

Authors:  C C Crowe; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

7.  Bacteremic infections due to clindamycin-resistant streptococci.

Authors:  M S Drapkin; A W Karchmer; R C Moellering
Journal:  JAMA       Date:  1976-07-19       Impact factor: 56.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.